A clinical trial to understand the effects of concurrently prescribed anticonvulsant mood stabilizer medications on the efficacy , cognitive adverse effects and brain electrical changes with electroconvulsive therapy

Phase 2

Completed

• Conditions: Health Condition 1: null- Bipolar Affective Disorders; schizoaffective disorder, schizophrenia

• Registration Number: CTRI/2014/07/004778
• Lead Sponsor: ational Institute of Mental Health and Neurosciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 90

Inclusion Criteria

1.Referred by treating team for ECT and on anticonvulsants for reasons other than epilepsy.

2.Either Sex

3.Age 18 to 60 years

4.Informed consent for study

Exclusion Criteria

1.Mental retardation (clinical examination)

2.Organic brain disease (by history and clinical examination)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical Global Impression (severity) â?? maximum score 7Timepoint: On the day after the third, sixth and last ECT(electroconvulsive therapy) sessions

Secondary Outcome Measures

Name	Time	Method
YMRS(Young Mania Rating Scale), HDRS(Hamilton Depression Rating Scale), PGI(Gognitive tests)Timepoint: Measured at the end of first and second weeks and before discharge.